Each year, the UK College of Pharmacy invites scientists from across campus and the nation to discuss the latest scientific advances in pharmaceutical sciences. 

The Therapeutics, Outcomes, Discovery & Delivery (TODD) Symposium brings together scientists from various disciplines for a day of seminars, poster sessions, and conversation. The TODD Symposium will feature recent advances in the translation of big data to provide new insights into diseases (cancer, substance use disorders, and cardiovascular) affecting the Commonwealth as well as discoveries of therapeutics and diagnostics to address unmet clinical needs.

Lunch will be provided to those who register by September 3, 2018. 

Keynote Speakers: 

William Douglas Figg Sr., PharmD, MBA
Deputy Chief, Genitourinary Malignancies Branch
National Institute of Health
"Androgen Uptake in Prostate Cancer: Passive or Active" 

Atul Butte, MD, Ph.D.
Professor, Priscilla Chan and Mark Zuckerberg Distinguished Professor
University of California, San Francisco
"Translating a Trillion Points of Data into Therapies, Diagnostics, and New Insights into Disease"

Featured Speakers:

Jill Kolesar, PharmD
Director, Early Phase Clinical Trials Center
Co-Director, Molecular Tumor Board
Professor, UK College of Pharmacy
"Precision Medicine and Big Data: Opportunities for Cancer Drug Development"

Tim Tracy, Ph.D.
CEO, Aprecia Pharmaceuticals
"3D Printing and Precision Medicine"

A panel discussion of Clinical Aspects of Precision Medicine will include the following UK experts:
Dr. Susan Smyth
Precision Medicine Initiatives in the Cardiovascular Service Line
Director, Gill Heart and Vascular Institute
Chief, Division of Cardiovascular Medicine
Jeff Gill Professor of Cardiology

Dr. Jill Kolesar
Markey Cancer Center Precision Medicine Initiatives 
Professor, College of Pharmacy
Director, Precision Medicine Center, Markey Cancer Center

Dr. Shulin Zhang
Laboratory Capabilities Supporting Precision Medicine
Director, Genomics Core Laboratory
Professor, Pathology and Laboratory Medicine

Dr. C. Darrell Jennings
Laboratory Reporting Oversight in the Era of Genomics
Chair & Professor, Pathology and Laboratory Medicine